title: Citalopram-induced diplopia.
authors.forename: Karin
authors.initials: K
authors.lastname: Dorell
authors.forename: Mary Ann
authors.initials: MA
authors.lastname: Cohen
authors.forename: Shirish S
authors.initials: SS
authors.lastname: Huprikar
authors.forename: Jack M
authors.initials: JM
authors.lastname: Gorman
authors.forename: Makeda
authors.initials: M
authors.lastname: Jones
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects* / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use; D015283:Citalopram / Q000009:adverse effects* / Q000627:therapeutic use; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D004172:Diplopia / Q000139:chemically induced*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006679:HIV Seropositivity / Q000523:psychology*; D019698:Hepatitis C, Chronic / Q000523:psychology*; D006801:Humans; D008875:Middle Aged; D000077152:Olanzapine; D011605:Psychoses, Substance-Induced / Q000188:drug therapy; D012017:Referral and Consultation
chemical_list: D019380:Anti-HIV Agents; D018687:Antidepressive Agents, Second-Generation; D000998:Antiviral Agents; D015283:Citalopram; D001569:Benzodiazepines; D000077152:Olanzapine